 Connection
Anum Shahzad to Humans
This is a "connection" page, showing publications Anum Shahzad has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.026 |
|
|
|
-
Babar F, Cheema AM, Ahmad Z, Sarfraz A, Sarfraz Z, Ashraff H, Tayyab H, Bajwa AM, Ali H, Sarfraz M, Shahzad A, Sabzwari SRA. Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic Review. Curr Cardiol Rep. 2023 07; 25(7):761-779.
Score: 0.006
-
Pelayo J, Shahzad A, Peterson E, Pressman G. Platypnea-orthodeoxia syndrome in patent foramen ovale and fenestrated atrial septal aneurysm with normal right atrial pressure: what is the culprit? BMJ Case Rep. 2021 Jul 01; 14(7).
Score: 0.005
-
Gulab A, Torres R, Pelayo J, Lo KB, Shahzad A, Pradhan S, Rangaswami J. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights. Expert Rev Cardiovasc Ther. 2021 Jun; 19(6):547-556.
Score: 0.005
-
Lo KB, Toroghi HM, Salacup G, Jiang J, Bhargav R, Quintero E, Balestrini K, Shahzad A, Mathew RO, McCullough PA, Rangaswami J. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes. Rev Cardiovasc Med. 2021 Mar 30; 22(1):199-206.
Score: 0.005
-
Oliveros E, Oni ET, Shahzad A, Kluger AY, Lo KB, Rangaswami J, McCullough PA. Benefits and Risks of Continuing Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Mineralocorticoid Receptor Antagonists during Hospitalizations for Acute Heart Failure. Cardiorenal Med. 2020; 10(2):69-84.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|